Skip to content
OpenCapital
Get started

Alumis Inc. ALMS Other Research And Development Expense

Other Research And Development Expense at other companies

Celanese Corporation logo
Celanese CorporationCE
$0—
Corvex logo
Corvex MOVE
$899K+12.4%
Disc Medicine logo
Disc MedicineIRON
$2.17M+18.2%
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$18.67M-34.4%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.49M+25.5%

Segments

By segment

See full
Single Reportable$2.37M+3.2%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×—

Profitability

See full
Operating margin-5,364%—
Net margin-2,825.7%—
FCF margin-4,487.4%—

Returns & leverage

See full
Return on equity-64.6%—
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×